Tay Jeannie, Thompson Campbell H, Brinkworth Grant D
Commonwealth Scientific and Industrial Research Organisation (CSIRO)-Food and Nutrition Flagship, Adelaide, South Australia 5000, Australia; email:
Annu Rev Nutr. 2015;35:389-424. doi: 10.1146/annurev-nutr-121214-104422. Epub 2015 May 6.
The primary therapeutic target for diabetes management is the achievement of good glycemic control, of which glycated hemoglobin (HbA1c) remains the standard clinical marker. However, glycemic variability (GV; the amplitude, frequency, and duration of glycemic fluctuations around mean blood glucose) is an emerging target for blood glucose control. A growing body of evidence supports GV as an independent risk factor for diabetes complications. Several techniques have been developed to assess and quantify intraday and interday GV. Additionally, GV can be influenced by several nutritional factors, including carbohydrate quality, quantity; and distribution; protein intake; and fiber intake. These factors have important implications for clinical nutrition practice and for optimizing blood glucose control for diabetes management. This review discusses the available evidence for GV as a marker of glycemic control and risk factor for diabetes complications. GV quantification techniques and the influence of nutritional considerations for diabetes management are also discussed.
糖尿病管理的主要治疗目标是实现良好的血糖控制,糖化血红蛋白(HbA1c)仍是其中的标准临床指标。然而,血糖变异性(GV;即血糖围绕平均血糖波动的幅度、频率和持续时间)正成为血糖控制的一个新目标。越来越多的证据支持血糖变异性作为糖尿病并发症的独立危险因素。已经开发了几种技术来评估和量化日内及日间血糖变异性。此外,血糖变异性会受到多种营养因素的影响,包括碳水化合物的质量、数量和分布;蛋白质摄入量;以及纤维摄入量。这些因素对临床营养实践以及优化糖尿病管理中的血糖控制具有重要意义。本综述讨论了有关血糖变异性作为血糖控制指标和糖尿病并发症危险因素的现有证据。还讨论了血糖变异性量化技术以及营养因素对糖尿病管理的影响。